Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Oncogene|September 29, 2020
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitorsYezi Zhu, Susan L Dalrymple, Ilsa Coleman, et al.
Cancer Immunology Research|October 4, 2017
Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor MicroenvironmentYuki Muroyama, Thomas R Nirschl, Christina M Kochel, et al.
The American Journal of Surgical Pathology|February 15, 2017
Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic InflammationDaniel F Boyer, Penelope A McKelvie, Laurence de Leval, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 12, 2012
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumorsRoeland F de Wilde, Christopher M Heaphy, Anirban Maitra, et al.
Nucleic Acids Research|December 1, 2023
DAXX promotes centromeric stability independently of ATRX by preventing the accumulation of R-loop-induced DNA double-stranded breaksLia M Pinto, Alexandros Pailas, Max Bondarchenko, et al.
The American Journal of Pathology|March 27, 2018
Comprehensive Evaluation of Programmed Death-Ligand 1 Expression in Primary and Metastatic Prostate CancerMichael C Haffner, Gunes Guner, Diana Taheri, et al.
JCI Insight|March 16, 2021
Resistance to androgen receptor signaling inhibition does not necessitate development of neuroendocrine prostate cancerW Nathaniel Brennen, Yezi Zhu, Ilsa M Coleman, et al.
Oncotarget|May 4, 2018
PD-L1 expression in medulloblastoma: an evaluation by subgroupAllison M Martin, Christopher J Nirschl, Magda J Polanczyk, et al.
Plos One|July 2, 2014
Telomerase variant A279T induces telomere dysfunction and inhibits non-canonical telomerase activity in esophageal carcinomasYuwei Zhang, Rodrigo Calado, Mahadev Rao, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Pageof 13